Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Antibe_Therapeutics> ?p ?o. }
Showing items 1 to 46 of
46
with 100 items per page.
- Antibe_Therapeutics abstract "Antibe Therapeutics is a Toronto-based pharmaceutical company that develops inflammation-reducing drugs based on gaseous mediator technology. Antibe was founded by John L. Wallace, also a co-founder of NicOx, the first company to develop drugs utilizing gaseous mediators. Antibe's science advisory board includes Louis Ignarro, awarded the 1998 Nobel Prize for the basic research that underpins Antibe's technology, and Daniel K. Podolsky, president of the University of Texas Southwestern Medical Center.".
- Antibe_Therapeutics industry Pharmaceutical_industry.
- Antibe_Therapeutics keyPerson John_L._Wallace.
- Antibe_Therapeutics type Public_company.
- Antibe_Therapeutics wikiPageExternalLink conference.html.
- Antibe_Therapeutics wikiPageExternalLink www.antibethera.com.
- Antibe_Therapeutics wikiPageID "29005145".
- Antibe_Therapeutics wikiPageRevisionID "598768072".
- Antibe_Therapeutics hasPhotoCollection Antibe_Therapeutics.
- Antibe_Therapeutics homepage www.antibethera.com.
- Antibe_Therapeutics industry Pharmaceutical_industry.
- Antibe_Therapeutics keyPeople "Dan Legault JD, CEO; Dr. Michael Bumby, CFO; Dr. John L. Wallace, Chief Science Officer".
- Antibe_Therapeutics locationCity "Toronto".
- Antibe_Therapeutics locationCountry "Canada".
- Antibe_Therapeutics logo "Antibe_Therapeutics_logo.jpg".
- Antibe_Therapeutics name "Antibe Therapeutics Inc.".
- Antibe_Therapeutics type Public_company.
- Antibe_Therapeutics subject Category:Pharmaceutical_companies_of_Canada.
- Antibe_Therapeutics type Abstraction100002137.
- Antibe_Therapeutics type Company108058098.
- Antibe_Therapeutics type DrugCompany108002578.
- Antibe_Therapeutics type Group100031264.
- Antibe_Therapeutics type Institution108053576.
- Antibe_Therapeutics type Organization108008335.
- Antibe_Therapeutics type PharmaceuticalCompaniesOfFrance.
- Antibe_Therapeutics type SocialGroup107950920.
- Antibe_Therapeutics type YagoLegalActor.
- Antibe_Therapeutics type YagoLegalActorGeo.
- Antibe_Therapeutics type YagoPermanentlyLocatedEntity.
- Antibe_Therapeutics type Agent.
- Antibe_Therapeutics type Company.
- Antibe_Therapeutics type Organisation.
- Antibe_Therapeutics type Organization.
- Antibe_Therapeutics type Agent.
- Antibe_Therapeutics type SocialPerson.
- Antibe_Therapeutics type Thing.
- Antibe_Therapeutics comment "Antibe Therapeutics is a Toronto-based pharmaceutical company that develops inflammation-reducing drugs based on gaseous mediator technology. Antibe was founded by John L. Wallace, also a co-founder of NicOx, the first company to develop drugs utilizing gaseous mediators. Antibe's science advisory board includes Louis Ignarro, awarded the 1998 Nobel Prize for the basic research that underpins Antibe's technology, and Daniel K.".
- Antibe_Therapeutics label "Antibe Therapeutics".
- Antibe_Therapeutics sameAs m.0dlnd1k.
- Antibe_Therapeutics sameAs Q16829017.
- Antibe_Therapeutics sameAs Q16829017.
- Antibe_Therapeutics sameAs Antibe_Therapeutics.
- Antibe_Therapeutics wasDerivedFrom Antibe_Therapeutics?oldid=598768072.
- Antibe_Therapeutics homepage www.antibethera.com.
- Antibe_Therapeutics isPrimaryTopicOf Antibe_Therapeutics.
- Antibe_Therapeutics name "Antibe Therapeutics Inc.".